Epstein David R (Director at AgomAb Therapeutics NV) purchased (open market) 5,000 shares at $8.57/share on 2026-10-05 (2 transactions total in this filing) [FILING TOTAL: $86,350 purchased (open market)]. [NO 10b5-1 PLAN]